MORE►
biotech
Panelists at the BioNTX summit family office discussion included, from left, Timothy Morris of Aacolade Pharma, Vic Stone of Alloy Therapeutics, Justin Yang of GHIC, and Yizhen Dong of Echo Investment Capital. The discussion was moderated by Weaver’s Tyler Ridley. [Photo: BioNTX]
Keys to Tapping Family Office Money: Pinpoint Their Passion, and ‘One Meeting in Person Equals 1,000 Emails’
by Glenn Hunter | Oct 24, 2024
Fundraising has slowed and valuations are down, but biotech founders could have a lifeline in family office investments, panelists at the recent BioNTX summit in Arlington agreed. They said succeeding with these investors can take time, a lot of education, and a compelling, well-crafted story that connects emotionally with the family.
by Nicole Ward, DRC Data Journalist |
Aug 14, 2024
Carter Inc. aims to be the first call for both corporate and high-stakes biotech relocations, working to keep transitions smooth and operations on track.
MORE►
by Nicole Ward, DRC Data Journalist |
Jul 25, 2024
Verily, Alphabet's health tech subsidiary, is shifting its headquarters to Dallas-Fort Worth's Cypress Waters development, positioning the Google sister company at the heart of a growing healthcare and tech ecosystem.
MORE►
by Quincy Preston |
Mar 5, 2024
According to a new report from Dallas-based JLL, society is accelerating the volume of data it creates at a rapid rate—and that data is foundational to how we work, live, and play. That's led to sharply increasing demand for data centers in a time of tightening supply, forcing a shift toward secondary and new, emerging markets.
MORE►
[Photo: GoodWheat]
Celeb Mom Camila Alves McConaughey Touts High-Fiber GoodWheat Pasta for Picky Eaters
by Lance Murray | Oct 6, 2023
It's national pasta month. The Texas mother, author, and philanthropist—married to Matthew McConaughey—has partnered with the Dallas-connected "better-for-you" pasta brand launched by Arcadia Biosciences. To entice families, it offers a "clean-plate guarantee."
MORE►
by Quincy Preston |
Sep 27, 2023
The rebrand "marks the start of our next chapter of growth," says Venture Dallas Chair Aaron Pierce. The nonprofit's 2023 summit, backed by JPMorgan Chase and Perot Jain, is set for October 25.
MORE►
by Quincy Preston and Lance Murray |
Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
by Dallas Innovates | Staff Report |
Jul 28, 2023
“Delivering these projects will help to increase the speed-to-market and meet the overwhelming demand for new medicines," said Richard Meserole, president of Fluor’s advanced technologies and life sciences business.
MORE►
Parker Health CEO and Founder Vincent Lopez is a 2023 Forbes 30 Under 30 lister in healthcare. [Photo: Parker Health]
Dallas- and D.C.-Based Biotech Raises $25M to Propel Healthcare Innovation
by Quincy Preston | Jul 18, 2023
Parker Health's cloud Health Management System is the first in the U.S. to build on the Fast Healthcare Interoperability Resources—or FHIR—standard to create an interoperable, affordable, and compliant cloud-based platform. The Parker Suite aims to unify patient-centric data, biometrics, diagnostic tools, patient outcomes, care delivery, practitioner engagement, and pharmaceuticals for the healthcare ecosystem.
MORE►
by Nicole Ward, DRC Data Journalist |
Jun 8, 2023
Elina Lavit, originally from the Soviet Union, charted a new course in 2021. Swapping San Francisco for Dallas, she's now steering business development at OncoNano Medicine, a North Texas biotech that aims to revolutionize cancer treatment.
MORE►
by Lance Murray |
Jun 6, 2023
VanTrust Real Estate, which has an office in Dallas, has announced a new division that is designed to match its real estate expertise and capital resources with both public and private sector clients in the life sciences, R&D, institutional, governmental, biotech, pharmaceutical and technology industries....
MORE►
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
Lantern Pharma CEO Panna Sharma [Courtesy: Lantern Pharma]
Busting the Brain’s Firewall: How Lantern Pharma’s Algorithms Can Predict a Drug’s Ability to Reach the Brain
by Lance Murray | May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Nicole Ward, DRC Data Journalist |
Feb 22, 2023
The campaign builds on the region's thriving tech sector as the foundation of Dallas-Fort Worth's growing biotech and life science ecosystem. “What we’re seeing now is the cumulative effect of convergence across industries—and that gives DFW an edge," says Mike Rosa, the DRC's economic development chief.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
MORE►
by Sandra Engelland |
Feb 15, 2023
From AI to human longevity to xTech, North Texas experts George Brody of InfoNet of Things and Anurag Jain of Perot Jain, along with Mike Bechtel of Deloitte, predict a range of emerging technologies set to transform the world in 2023 and beyond.
MORE►
